Last: | $21.35 |
---|---|
Change Percent: | -1.19% |
Open: | $21.19 |
Close: | $21.35 |
High: | $21.56 |
Low: | $21.135 |
Volume: | 2,141,346 |
Last Trade Date Time: | 05/14/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$21.35 | $21.19 | $21.35 | $21.56 | $21.135 | 2,141,346 | 05-14-2024 |
$20.94 | $20.57 | $20.94 | $21.08 | $20.47 | 1,929,895 | 05-13-2024 |
$20.42 | $20.41 | $20.42 | $20.75 | $20.295 | 1,333,778 | 05-10-2024 |
$20.51 | $20.37 | $20.51 | $20.68 | $20.11 | 2,023,526 | 05-09-2024 |
$20.37 | $20.23 | $20.37 | $20.505 | $20.08 | 2,114,086 | 05-08-2024 |
$20.4 | $20.69 | $20.4 | $20.97 | $20.37 | 2,438,275 | 05-07-2024 |
$20.68 | $19.75 | $20.68 | $20.79 | $19.59 | 3,180,132 | 05-06-2024 |
$19.61 | $20 | $19.61 | $20.3 | $19.41 | 3,217,591 | 05-03-2024 |
$19.5 | $19.44 | $19.5 | $19.89 | $18.11 | 4,580,564 | 05-02-2024 |
$18.83 | $18.61 | $18.83 | $19.12 | $18.59 | 2,398,395 | 05-01-2024 |
$18.61 | $18.84 | $18.61 | $18.92 | $18.56 | 2,338,097 | 04-30-2024 |
$18.9 | $18.69 | $18.9 | $19.04 | $18.69 | 2,158,786 | 04-29-2024 |
$18.55 | $18.43 | $18.55 | $18.68 | $18.33 | 2,049,767 | 04-26-2024 |
$18.42 | $18.62 | $18.42 | $18.73 | $18.2 | 1,461,584 | 04-25-2024 |
$18.71 | $18.44 | $18.71 | $18.75 | $18.11 | 1,999,159 | 04-24-2024 |
$18.52 | $17.96 | $18.52 | $18.54 | $17.82 | 1,699,256 | 04-23-2024 |
$18 | $17.97 | $18 | $18.11 | $17.79 | 1,551,049 | 04-22-2024 |
$17.82 | $17.88 | $17.82 | $18.025 | $17.38 | 3,612,206 | 04-19-2024 |
$17.86 | $17.9 | $17.86 | $18.235 | $17.81 | 2,129,589 | 04-18-2024 |
$17.87 | $17.89 | $17.87 | $17.92 | $17.4325 | 2,798,568 | 04-17-2024 |
News, Short Squeeze, Breakout and More Instantly...
Organon & Co. Company Name:
OGN Stock Symbol:
NYSE Market:
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...
Organon (NYSE: OGN) (“Organon”), a global healthcare company with a focus on women’s health, announced today that it, together with Organon Foreign Debt Co-Issuer B.V., a direct wholly-owned subsidiary of Organon, as co-issuer (the “Co-Issuer” and, together with...
Organon (NYSE: OGN) (“Organon”), a global healthcare company with a focus on women’s health, announced today that it, together with Organon Foreign Debt Co-Issuer B.V., a direct wholly-owned subsidiary of Organon, as co-issuer (the “Co-Issuer” and, together with...